Chief, Preclinical Microbicide and Prevention Research Branch, Prevention Sciences Program, Division
Division of AIDS/NIH
Frederick, Maryland
James E. Cummins, Jr., Ph.D. is currently the Chief of the Preclinical Microbicide and Prevention Research Branch in the Prevention Sciences Program within the Division of AIDS (DAIDS) at the National Institute of Allergy and Infectious Diseases (NIAID). He leads a team that manages a portfolio of grants and contracts supporting the preclinical development of non-vaccine biomedical prevention products. Active grants in the portfolio support the development and optimization of the next generation of HIV prevention products – including sustained release/long-acting products and multi-purpose prevention strategies. These funding mechanisms have supported development of a range of product types (e.g., gels, films, intravaginal rings, suppositories, and long-acting injectables), and facilitated the advancement of 12 products into NIAID-sponsored clinical trials. More recently, Dr. Cummins has expanded the capabilities of his Branch to include support for the development of pediatric formulations HIV treatment and prevention, and associated co-infections.
Current Resources and Opportunities to Collaborate for Pediatric Formulation Development
Wednesday, October 25, 2023
10:30 AM – 11:00 AM ET